Integrated imaging approach to tumor model mice using bioluminescence imaging and magnetic resonance imaging

Molecular Imaging

Volumn 9, Issue 3, 2010, Pages 163-172

  Inoue, Yusuke ^a,b,c,d,e   Masutani, Yoshitaka ^a,b,c,d   Kiryu, Shigeru ^a,b,c,d   Haishi, Tomoyuki ^a,b,c,d   Watanabe, Makoto ^a,b,c,d   Tojo, Arinobu ^a,b,c,d   Ohtomo, Kuni ^a,b,c,d  

^a Department of Radiology   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^d MRTechnology Inc   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLUMINESCENCE IMAGING; COREGISTRATION; DISEASE MODELS; DISEASE PROGRESSION; FLAT PLATE; FLUORESCENCE IMAGING; IMAGING FIELDS; INTEGRATED IMAGING; MOUSE TUMORS; PRACTICAL METHOD; REGISTRATION ERROR; TUMOR CELLS; TUMOR MODELS;

BIOLUMINESCENCE; IMAGE REGISTRATION; MAGNETIC RESONANCE; PHOSPHORESCENCE; TUMORS;

MAGNETIC RESONANCE IMAGING;

ANIMAL; ARTICLE; COMPUTER ASSISTED DIAGNOSIS; DISEASE MODEL; DRUG SCREENING; EVALUATION; HUMAN; INSTRUMENTATION; LUMINESCENCE; METHODOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUMINESCENT MEASUREMENTS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77953498846     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2010.00013     Document Type: Article

References (27)

1. Contag CH, Jenkins D, Contag PR, et al. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2000; 2: 41-52.
2. Edinger M, Cao YA, Hornig YS, et al. Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 2002; 38: 2128-36.
3. Contag CH, Ross BD. It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imaging 2002; 16: 378-87.
4. Contag CH, Bachmann MH. Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 2002; 4: 235-60.
5. Inoue Y, Izawa K, Tojo A, et al. Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy. Exp Hematol 2007; 35: 407-15.
6. Rehemtulla A, Stegman LD, Cardozo SJ, et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2000; 2: 491-5.
7. Smith MC, Luker KE, Garbow JR, et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 2004; 64: 8604-12.
8. Mouchess ML, Sohara Y, Nelson MD Jr, et al. Multimodal imaging analysis of tumor progression and bone resorption in a murine cancer model. J Comput Assist Tomogr 2006; 30: 525-34.
9. Szentirmai O, Baker CH, Lin N, et al. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect. Neurosurgery 2006; 58: 365-72.
10. Allard M, Côté D, Davidson L, et al. Combined magnetic resonance and bioluminescence imaging of live mice. J Biomed Opt 2007; 12: 034018.
11. Beattie BJ, Klose AD, Le CH, et al. Registration of planar bioluminescence to magnetic resonance and x-ray computed tomography images as a platform for the development of bioluminescence tomography reconstruction algorithms. J Biomed Opt 2009; 14: 024045.
12. Inoue Y, Tojo A, Sekine R, et al. In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals. Eur J Nucl Med Mol Imaging 2006; 33: 557-65.
13. Inoue Y, Kiryu S, Izawa K, et al. Comparison of subcutaneous and intraperitoneal injection of D-luciferin for in vivo bioluminescence imaging. Eur J Nucl Med Mol Imaging 2009; 36: 771-9.
14. Inoue Y, Nomura Y, Haishi T, et al. Imaging living mice using a 1-T compact MRI system. J Magn Reson Imaging 2006; 24: 901-7.
15. Haishi T, Uematsu T, Matsuda Y, et al. Development of a 1.0 T MR microscope using a Nd-Fe-B permanent magnet. Magn Reson Imaging 2001; 19: 875-80.
16. Kiryu S, Inoue Y, Watanabe M, et al. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine. Magn Reson Imaging 2009; 27: 101-7.
17. Bakker CJ, Moerland MA, Bhagwandien R, et al. Analysis of machine-dependent and object-induced geometric distortion in 2DFT MR imaging. Magn Reson Imaging 1992; 10: 597-608.
18. Mocanu JD, Moriyama EH, Chia MC, et al. Combined in vivo bioluminescence and fluorescence imaging for cancer gene therapy. Mol Imaging 2004; 3: 352-5.
19. Carlsen H, Moskaug JO, Fromm SH, et al. In vivo imaging of NFkappa B activity. J Immunol 2002; 168: 1441-6.
20. Minn AJ, Kang Y, Serganova I, et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 2005; 115: 44-55.
21. Burch S, Bisland SK, Wilson BC, et al. Multimodality imaging for vertebral metastases in a rat osteolytic model. Clin Orthop Relat Res 2007; 454: 230-6.
22. Inoue Y, Izawa K, Yoshikawa K, et al. In vivo fluorescence imaging of the reticuloendothelial system using quantum dots in combination with bioluminescent tumour monitoring. Eur J Nucl Med Mol Imaging 2007; 34: 2048-56.
23. Medintz IL, Uyeda HT, Goldman ER, et al. Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 2005; 4: 435-46.
24. Hotz CZ. Applications of quantum dots in biology: an overview. Methods Mol Biol 2005; 303: 1-17.
25. Weagle G, Paterson PE, Kennedy J, et al. The nature of the chromophore responsible for naturally occurring fluorescence in mouse skin. J Photochem Photobiol B 1988; 2: 313-20.
26. Chen MC, Tsang YM, Stark DD, et al. Hepatic metastases: rat models for imaging research. Magn Reson Imaging 1989; 7: 1-8.
27. Leimgruber A, Berger C, Cortez-Retamozo V, et al. Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle. Neoplasia 2009; 11: 459-68.